杜拉格卢提德在戒烟期间对酒精消费的影响
Leila Probst1,2, Sophie Monnerat1,2, Deborah R Vogt2
1Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland.
葡萄糖类-1 (GLP-1) 激动剂杜拉格卢提德在12周内显著降低了成年人的29%的酒精消耗. 这项研究支持GLP-1激动剂作为酒精使用障碍的潜在治疗方法.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 成 药物 药物 药物 药物
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 酒精使用障碍对全球健康造成重大负担,需要新的治疗目标.
- 临床前研究表明,葡萄糖类-1 (GLP-1) 激动剂可以减少与成有关的行为.
- 现有的人类临床试验对GLP-1对奖励过程的激动性产生了不确定的结果.
研究的目的:
- 为了评估GLP-1激动剂杜拉格卢提德在减少酒精消耗方面的疗效.
- 在12周后,分析杜拉格卢提德和安慰剂组之间酒精摄入量的差异.
- 调查杜拉格卢提德作为治疗酒精使用障碍的潜力.
主要方法:
- 一个双盲,随机,安慰剂对照试验的二次分析.
- 参与者接受了杜拉格卢提德或安慰剂12周.
- 使用多变量通用线性模型评估酒精消耗.
主要成果:
- 总共有151名参与者在基线时饮酒并完成了12周的分析.
- 与安慰剂 (P=0.04) 相比,杜拉格卢提德治疗导致酒精消费减少29% (P=0.04).
- 观察到的酒精摄入量减少与戒烟状态无关.
结论:
- 杜拉古胺在人类中显著降低了酒精消耗.
- 这些发现支持对GLP-1激动剂用于治疗物质使用障碍的研究.
- 对用于治疗成的GLP-1激动剂的进一步研究是有必要的.
更多相关视频
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
相关概念视频
CNS Depressants: Alcohol and Nicotine
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Drug Dependence
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
